Excipient GMP Quality Standards: One is Enough

July 2nd 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.

June 25th 2024

Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Close up the media plate on hand medical technicians working on bacterial culture and drug resistance of pathogens in laboratory. | Image Credit: © analysis121980 - stock.adobe.com

Patrick Lavery

June 26th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.

May 28th 2024

Quattrii Delivers Biologics and mRNA Molecules in Single Inhalation

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

European Pharmacopoeia Goes Digital

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Sandoz Recalls Cefazolin Due to Mispackaging, Opens Biosimilar Facility in Slovenia

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

Related Content

July 2nd 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.

June 25th 2024

Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Patrick Lavery

June 26th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.

May 28th 2024

Quattrii Delivers Biologics and mRNA Molecules in Single Inhalation

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

European Pharmacopoeia Goes Digital

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.